Thomas McGrath

Work Highlights

Highlights of Tom’s experience include:

- Linde: advising in relation to its US$90bn merger of equals with Praxair to create the largest industrial gas group in the world. We coordinated merger control filings in more than 20 jurisdictions worldwide, including in the U.S., EU and China.

- Novartis: advising on its transformative transactions to acquire GlaxoSmithKline’s global oncology business and sell its global vaccines business, its acquisition of Spinifex Pharmaceuticals and its sale of assets to Questcor (Mallinckrodt).

- Siemens: advising on its acquisitions of Invensys Rail Business, wind turbine producer Gamesa and the Rolls-Royce Energy aero-derivative gas turbine and compressor business.

- Takeda: advising in relation to its US$62bn offer for Shire plc, the largest ever outbound M&A deal by a Japanese company.

- Bayer AG: advising on the US$7.6bn sale of its animal health business to Elanco Animal Health to create a leading global animal health company.

- Nestlé S.A.: advising on the US$10bn sale of its Nestlé Skin Health business.

- Glencore: advising: on its US$29bn merger with Xstrata to create the world’s leading trading and mining company.

- Deutsche Börse AG: advising on its terminated merger with the London Stock Exchange, having previously acted on its planned merger with NYSE Euronext.

- Air France KLM: advising on the defense of the air cargo cartel investigations and follow-on litigation.

Professional Memberships

Tom is a member of the Antitrust Section of the American Bar Association and is recognized in Chambers USA. He is recognized in Legal 500 USA and has been named to LawDragon’s 2024 "Top Litigation Lawyers in America." He currently serves as a member of Linklaters’ Partnership Board.

Practice Areas

Tom’s practice focuses on achieving antitrust approval for clients’ most important and complex cross-border M&A transactions, using a pragmatic approach to realize their commercial objectives. Tom also leads the Global U.S. Practice.

Tom has over 25 years’ experience working with clients across a range of sectors, including life sciences, pharmaceuticals, consumer goods, chemicals, engineered products, industrial gases, financial services, transportation, oil & gas and mining. He has served as co-head of Linklaters’ Global Life Sciences Group and Global Chemicals Group.

Tom advises on all aspects of antitrust law, including intellectual property licensing, cooperation with competitors and compliance. He also defends clients in criminal price-fixing investigations and private litigation. Tom regularly appears before the U.S. Department of Justice and Federal Trade Commission on both merger control and litigation matters.